|
1
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma SV, Bell DW, Settleman J and Haber
DA: Epidermal growth factor receptor mutations in lung cancer. Nat
Rev Cancer. 7:169–181. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu Q, Lanford GW, Hong H and Chen YH:
δ-Catenin as a potential cancer biomarker. Pathol Int. 64:243–246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medina M, Marinescu RC, Overhauser J and
Kosik KS: Hemizygosity of delta-catenin (CTNND2) is associated with
severe mental retardation in cri-du-chat syndrome. Genomics.
63:157–164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dai SD, Wang Y, Zhang JY, Zhang D, Zhang
PX, Jiang GY, Han Y, Zhang S, Cui QZ and Wang EH: Upregulation of
δ-catenin is associated with poor prognosis and enhances
transcriptional activity through Kaiso in non-small-cell lung
cancer. Cancer Sci. 102:95–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang T, Chen YH, Hong H, Zeng Y, Zhang J,
Lu JP, Jeansonne B and Lu Q: Increased nucleotide polymorphic
changes in the 5′-untranslated region of δ-catenin (CTNND2) gene in
prostate cancer. Oncogene. 28:555–564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fang Y, Li Z, Wang X and Zhang S:
Expression and biological role of δ-catenin in human ovarian
cancer. J Cancer Res Clin Oncol. 138:1769–1776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nopparat J, Zhang J, Lu JP, Chen YH, Zheng
D, Neufer PD, Fan JM, Hong H, Boykin C and Lu Q: δ-catenin, a
Wnt/β-catenin modulator, reveals inducible mutagenesis promoting
cancer cell survival adaptation and metabolic reprogramming.
Oncogene. 34:1542–1552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim H, He Y, Yang I, Zeng Y, Kim Y, Seo
YW, Murnane MJ, Jung C, Lee JH, Min JJ, et al: δ-Catenin promotes
E-cadherin processing and activates β-catenin-mediated signaling:
Implications on human prostate cancer progression. Biochim Biophys
Acta. 1822:509–521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu XL, Liu LD, Zhang SG, Dai SD, Li WY
and Zhang L: Correlation between expression and significance of
δ-catenin, CD31, and VEGF of non-small cell lung cancer. Genet Mol
Res. 14:13496–13503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li XY, Liu SL, Cha N, Zhao YJ, Wang SC, Li
WN, Wang EH and Wu GP: Transcription expression and clinical
significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural
effusions from patients with lung cancer. Clin Dev Immunol.
2012:9049462012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Viloria-Petit AM and Wrana JL: The
TGFbeta-Par6 polarity pathway: Linking the Par complex to EMT and
breast cancer progression. Cell Cycle. 9:623–624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zuo W and Chen YG: Specific activation of
mitogen-activated protein kinase by transforming growth factor-beta
receptors in lipid rafts is required for epithelial cell
plasticity. Mol Biol Cell. 20:1020–1029. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertram JS and Janik P: Establishment of a
cloned line of Lewis lung carcinoma cells adapted to cell culture.
Cancer Lett. 11:63–73. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O'Reilly MS, Holmgren L, Shing Y, Chen C,
Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J:
Angiostatin: A novel angiogenesis inhibitor that mediates the
suppression of metastases by a Lewis lung carcinoma. Cell.
79:315–328. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mali P, Yang L, Esvelt KM, Aach J, Guell
M, DiCarlo JE, Norville JE and Church GM: RNA-guided human genome
engineering via Cas9. Science. 339:823–826. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cong L, Ran FA, Cox D, Lin S, Barretto R,
Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al: Multiplex
genome engineering using CRISPR/Cas systems. Science. 339:819–823.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Evan GI and Littlewood TD: The role of
c-myc in cell growth. Curr Opin Genet Dev. 3:44–49. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Claassen GF and Hann SR: A role for
transcriptional repression of p21CIP1 by c-Myc in overcoming
transforming growth factor beta-induced cell-cycle arrest. Proc
Natl Acad Sci USA. 97:pp. 9498–9503. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chin YE, Kitagawa M, Su WC, You ZH,
Iwamoto Y and Fu XY: Cell growth arrest and induction of
cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1.
Science. 272:719–722. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Macleod KF, Sherry N, Hannon G, Beach D,
Tokino T, Kinzler K, Vogelstein B and Jacks T: p53-dependent and
independent expression of p21 during cell growth, differentiation,
and DNA damage. Genes Dev. 9:935–944. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y: Wnt signaling in development and
disease. Cell Biosci. 2:142012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salic A, Lee E, Mayer L and Kirschner MW:
Control of beta-catenin stability: Reconstitution of the
cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol
Cell. 5:523–532. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cohen P and Goedert M: GSK3 inhibitors:
Development and therapeutic potential. Nat Rev Drug Discov.
3:479–487. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Visvader JE and Lindeman GJ: Cancer stem
cells: Current status and evolving complexities. Cell Stem Cell.
10:717–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamada KM and Cukierman E: Modeling tissue
morphogenesis and cancer in 3D. Cell. 130:601–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bissell MJ and Labarge MA: Context, tissue
plasticity, and cancer: Are tumor stem cells also regulated by the
microenvironment? Cancer Cell. 7:17–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Viloria-Petit AM, David L, Jia JY, Erdemir
T, Bane AL, Pinnaduwage D, Roncari L, Narimatsu M, Bose R, Moffat
J, et al: A role for the TGFbeta-Par6 polarity pathway in breast
cancer progression. Proc Natl Acad Sci USA. 106:pp. 14028–14033.
2009; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giard DJ, Aaronson SA, Todaro GJ, Arnstein
P, Kersey JH, Dosik H and Parks WP: In vitro cultivation of human
tumors: Establishment of cell lines derived from a series of solid
tumors. J Natl Cancer Inst. 51:1417–1423. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reynolds A, Leake D, Boese Q, Scaringe S,
Marshall WS and Khvorova A: Rational siRNA design for RNA
interference. Nat Biotechnol. 22:326–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Silva JM, Li MZ, Chang K, Ge W, Golding
MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR, et al:
Second-generation shRNA libraries covering the mouse and human
genomes. Nat Genet. 37:1281–1288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho SW, Kim S, Kim JM and Kim JS: Targeted
genome engineering in human cells with the Cas9 RNA-guided
endonuclease. Nat Biotechnol. 31:230–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsu PD, Scott DA, Weinstein JA, Ran FA,
Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, et al: DNA
targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol.
31:827–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamada N, Noguchi S, Mori T, Naoe T, Maruo
K and Akao Y: Tumor-suppressive microRNA-145 targets catenin δ-1 to
regulate Wnt/β-catenin signaling in human colon cancer cells.
Cancer Lett. 335:332–342. 2013. View Article : Google Scholar : PubMed/NCBI
|
